EMZ Partners’ portfolio company FotoFinder Systems, a global leader in skin imaging solutions, has entered into a definitive agreement to acquire DermLite, a renowned provider of handheld dermatoscopes. This strategic merger marks a major milestone in dermoscopy, uniting two companies that share a track record of setting industry standards through groundbreaking achievements and a commitment to advancing dermatological care through innovation. The acquisition marks EMZ’s first investment in the United States.
By merging DermLite’s expertise in dermatoscope technology with FotoFinder’s state-of-the-art imaging systems, the newly formed group offers a comprehensive range of products and services for modern dermatological diagnostics and research. Clients will have access to a complete range of skin visualization tools, from handheld devices to Total Body Dermoscopy systems, on-premise or in the cloud, and powered by cutting-edge AI technology.
“We are excited to welcome DermLite to the FotoFinder family”, said Andreas Mayer, CEO at FotoFinder Systems. “This merger represents a significant step in our mission to facilitate early detection and accurate diagnosis of skin cancer worldwide. Our shared vision is to provide our customers with a seamless experience, offering everything they need for skin imaging under one roof. By combining DermLite’s renowned dermatoscope technology with our AI-powered imaging systems, we are forging a unified ecosystem that empowers clinicians with unmatched insights and capabilities.”
John Bottjer, President of DermLite, also looks forward to the new chapter: “Joining forces with FotoFinder aligns with our goals and values, promising to amplify our capabilities significantly. We’re excited for the opportunities this acquisition creates for innovation, growth, and learning, enabling us to provide clinicians with even more powerful tools for the discoveries of tomorrow.”
FotoFinder and DermLite share a vision of building the future of skin imaging together, reaffirming their commitment to innovation and excellence. This ambitious merger of two strong brands is set to enhance the existing product offerings and accelerate the development of new technologies and educational resources in dermatology and aesthetics.
“Building upon our joint successful growth path with FotoFinder since early 2022, we are excited to announce our investment in DermLite. This move establishes a leading player in dermoscopy, boasting a strong financial profile with clear double-digit EBITDA and an international presence in Germany and the United States. As shareholders and partners of the management teams, we look forward to jointly leveraging the substantial synergies between FotoFinder and DermLite,” says Klaus Maurer, Senior Partner at EMZ.
EMZ was advised by Venable, Lupp + Partner, and Taxess (Legal, Corporate, & Structure), ISP Healthcare (Commercial), RSM Ebner Stolz (Financial & Tax), Houlihan Lokey (M&A & Debt Advisory) as well as Goodwin Procter (Legal, Financing).
